• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. PT HYBRID GLEN POST REGENEREX; EXTEMITY - IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. PT HYBRID GLEN POST REGENEREX; EXTEMITY - IMPLANT Back to Search Results
Model Number N/A
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the comprehensive modular hybrid glenoid post - regenerex broke off the modular hybrid glenoid base.The patient got a comprehensive tsa shoulder implanted approximately 3 years ago.At 1-year control, the surgeon found via an x-ray the regenerex post was broken off the glenoid base.Furthermore, in the x-ray taken last month, the position of the post appears to have changed further.For now, doctors plan to monitor the progress, but reoperation may be a possibility in the future.Attempts have been made and there is no further information at this time.
 
Additional Manufacturer Narrative
(b)(4).G2: japan.H3: customer has indicated that the product will not be returned to zimmer biomet for investigation, as the device remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.H3 other text : remains implanted.
 
Event or Problem Description
No further event information is available at the time of this report.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.The following sections were corrected: b1 - product problem (e.G., defects/malfunctions) was inadvertently not clicked in original submission.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.Review of the device history record(s) identified no deviations or anomalies during manufacturing related to the reported event.Radiographs were provided and reviewed by a health care professional.Review of the available records identified the following: initial anatomic alignment and normal appearance of the right shoulder arthroplasty with subsequent post fracture.A definitive root cause cannot be determined.The reported event is confirmed as an x-ray was provided.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PT HYBRID GLEN POST REGENEREX
Common Device Name
EXTEMITY - IMPLANT
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer (Section G)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key18371688
Report Number0001825034-2023-03045
Device Sequence Number7617352
Product Code HSD
UDI-Device Identifier00880304459854
UDI-Public(01)00880304459854(17)290822(10)444370
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K060694
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue NumberPT-113950
Device Lot Number444370
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/29/2023
Supplement Date Received by Manufacturer02/21/2024
Initial Report FDA Received Date12/21/2023
Supplement Report FDA Received Date02/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/22/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-